These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 1206223)

  • 41. T-cell-specific human alloantisera to antigens segregating outside the major histocompatibility complex.
    Schacter B; Pollard K; Maylock R; Humphrey RL; Hsu SH; Bias WB
    Transplant Proc; 1977 Mar; 9(1):635-7. PubMed ID: 301310
    [No Abstract]   [Full Text] [Related]  

  • 42. HL-A Antigens and lymphocytotoxic antibodies in psoriasis vulgaris.
    Stenszky V; Nagy E; Szerze P; Ladányi E
    Dermatol Monatsschr; 1976 Jan; 162(1):35-8. PubMed ID: 955181
    [No Abstract]   [Full Text] [Related]  

  • 43. T cell-specific human alloantisera-detecting antigens segregating outside the major histocompatibility complex.
    Schacter B; Pollard K; Maylack F; Humphrey RL; Hsu SH; Bias WB
    Transplantation; 1976 Dec; 22(6):604-11. PubMed ID: 64007
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Lymphocytes HLA antigens expressivity after neuraminidase treatment (author's transl)].
    de Mouzon A; Ohayon E; Oksman-Domejean F; Ducos J
    Ann Immunol (Paris); 1976; 127(5):687-701. PubMed ID: 984732
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Anti-HLA, anti-human "Ia-like" and MLC blocking activity of human placental IgG.
    Jeannet M; Werner C; Ramirez E; Vassalli P; Faulk WP
    Transplant Proc; 1977 Jun; 9(2):1417-22. PubMed ID: 141758
    [No Abstract]   [Full Text] [Related]  

  • 46. Incidence of a weak HL-A W27 antigen in a Czech family.
    Májský A
    J Immunogenet; 1976 Jun; 3(3):211-3. PubMed ID: 965770
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The clinical importance of choosing the right assay for detection of HLA-specific donor-reactive antibodies.
    Sumitran-Karuppan S
    Transplantation; 1999 Aug; 68(4):502-9. PubMed ID: 10480407
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Incidence of anti-HL-A antibodies in patients under dialysis and in a transplantation program in relation to rejection].
    Erbenová E; Erben J
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove Suppl; 1976; 19(3):303-9. PubMed ID: 801077
    [No Abstract]   [Full Text] [Related]  

  • 49. Proceedings: Action of HL-A specific antibodies on platelets in vitro.
    Heinrich D; Kessler C; Stephinger U; Kunkel W; Mueller-Eckhardt C
    Thromb Diath Haemorrh; 1975 Sep; 34(1):348. PubMed ID: 1188795
    [No Abstract]   [Full Text] [Related]  

  • 50. Detection of anti-vascular endothelial cell antibodies with microcytotoxicity testing.
    Wang XM; Zhong HP; Zhou SF; Chen JP
    J Clin Lab Immunol; 1989 Feb; 28(2):73-8. PubMed ID: 2664185
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Evaluation of two sources of soluble HL-A antigens: platelets and serum.
    Pellegrino MA; Ferrone S; Pellegrino AG; Oh SK; Reisfeld RA
    Eur J Immunol; 1974 Apr; 4(4):250-5. PubMed ID: 4851933
    [No Abstract]   [Full Text] [Related]  

  • 52. [Intermediate antigens in the HL-A system].
    Seignalet J; Betuel H
    Nouv Rev Fr Hematol; 1972; 12(2):171-90. PubMed ID: 4118517
    [No Abstract]   [Full Text] [Related]  

  • 53. Common antigenic structures of HL-A antigens. 3. An HL-A common antigenic marker closely associated with HL-A alloantigenic activity and detected by use of rabbit anti-rhesus monkey cell membrane antibodies.
    Katagiri M; Tanigaki N; Kreiter VP; Pressman D
    Immunology; 1974 Sep; 27(3):487-500. PubMed ID: 4137582
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Heterogeneity of HL-A antigen preparations is due to variable sialic acid content.
    Parham P; Humphreys RE; Turner MJ; Strominger JL
    Proc Natl Acad Sci U S A; 1974 Oct; 71(10):3998-4001. PubMed ID: 4139707
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Immunofluorescence of HL-A antigens in kidney tissue.
    Sybesma JP; Kater L; Borst-Eilers E; de Planque BA; van Soelen T; Tuit G
    Proc Eur Dial Transplant Assoc; 1973; 10(0):406-11. PubMed ID: 4606644
    [No Abstract]   [Full Text] [Related]  

  • 56. Production of HL-A-specific antibodies in monkeys by immunization with soluble HL-A-antigens.
    Metzgar RS; Miller JL
    Transplantation; 1972 May; 13(5):467-71. PubMed ID: 4625450
    [No Abstract]   [Full Text] [Related]  

  • 57. Studies of the antibodies against HLA, Ia-like, Fc, and/or C3 receptors present in pretransplant sera: anti-B-cell antibodies not associated with accelerated graft loss.
    Soulillou JP; Peyrat MA; Guenel J
    Transplant Proc; 1978 Jun; 10(2):475-7. PubMed ID: 354139
    [No Abstract]   [Full Text] [Related]  

  • 58. [Reproduction and anti-HL-A antibody].
    Ebina K; Ishikawa K; Akashi M; Kozaka J
    Horumon To Rinsho; 1976 Jul; 24(7):631-5. PubMed ID: 986910
    [No Abstract]   [Full Text] [Related]  

  • 59. Constancy of cross reactivity patterns during the anti-HL-A response.
    Longo A; Tosi RM; Ferrara G; Azzolina G; Carminati G
    Transplantation; 1975 Dec; 20(6):503-11. PubMed ID: 1209727
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Radioiodination of rat hepatoma-specific antigens and retention of serological reactivity.
    Hannant D; Bowen JG; Price MR; Baldwin RW
    Br J Cancer; 1980 May; 41(5):716-23. PubMed ID: 6158964
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.